August 01, 2016
A new private lending outfit is targeting hedge fund investors who need instant liquidity but don’t want to cash out of their managers, offering these investors loans against their hedge fund stakes
July 29, 2016
July 28, 2016
Activist manager Sahm Adrangi’s firm has had a tough year, in part due to a big short bet against Dish Network.
July 27, 2016
July 26, 2016
July 25, 2016
Smaller or more niche-oriented players are hawking their wares to investors who want to allocate to activists but may be put off by the recent performance of big-name players.
July 22, 2016
July 21, 2016
Jeffrey Ubben’s activist firm built its fortunes in part based on its early success with now-struggling Valeant Pharmaceuticals International. With Valeant battling a 90 percent drop in its share price, can ValueAct outrun collateral damage to its reputation?
July 20, 2016
July 19, 2016
July 18, 2016
July 15, 2016
July 14, 2016
July 13, 2016
July 12, 2016
July 11, 2016
July 08, 2016
Firms like Tiger Global and Hound Partners have a long way to go to break-even, though they’ve rallied in the past.
The flagship funds managed by Citadel, Millennium and others posted either small losses or gains in June, a month when markets rocked by Brexit caused trouble for some other strategies.
July 07, 2016
July 06, 2016
The firm’s Pure Alpha II fund is off by double-digits this year, while its smaller risk-parity strategy has notched double-digit gains.
July 05, 2016
The firm, troubled by a drawn-out bribery investigation and less-than-stellar fund performance, continues its downward trajectory.
The firm slipped back into losing mode after snapping a negative streak in May.
July 01, 2016
David Einhorn’s flagship fund stayed narrowly positive but still trails the S&P 500.
Will a Trump presidency be good for hedge funds?
View previous results
All material subject to strictly enforced copyright laws. ©
Euromoney Institutional Investor PLC.
Sorry, you are not allowed to print this article.
Please contact us if you have any inquiry.